Mechanisms of mitochondrial disease suppression in Ndufs4 knockout mice
Ndufs4基因敲除小鼠线粒体疾病抑制机制
基本信息
- 批准号:9307448
- 负责人:
- 金额:$ 47.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-15 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcarboseAddressAdultAffectAgeAnimalsAttenuatedBiochemicalBiologyBlindnessBody Weight decreasedBrainCardiomyopathiesCell NucleusCessation of lifeChildCommunicationComplexCytoplasmDeacetylaseDefectDiseaseDisease ProgressionEncephalopathiesFRAP1 geneFailureGeneticGlucosidase InhibitorGoalsGrowthHealthHomeostasisHumanInheritedInterphase CellInterventionKidney DiseasesKnock-outKnockout MiceLactic AcidosisLeigh DiseaseLethargiesLiverMetabolicMitochondriaMitochondrial DiseasesMitochondrial Electron Transport Complex IMitochondrial ProteinsMolecularMotor SkillsMusMutationNADHNeonatalNerve DegenerationNeurologicNicotinamide MononucleotideOpticsPathologyPatientsPharmaceutical PreparationsPharmacologyPhosphorylationPlayProcessProteomicsReportingRoleSignal PathwaySignal TransductionSirolimusSymptomsTestingTissuesattenuationbasebrain tissueclinically relevanteffective therapyhuman diseaseimprovedimproved outcomeinfancyinhibitor/antagonistinsightintervention effectknockout animalmetabolomemetabolomicsmouse modelneurodegenerative phenotypenovel therapeuticsoverexpressionphosphoproteomicsrestorationtherapy development
项目摘要
7. Project Summary/Abstract
Deficiencies in complex I of the mitochondrial electron transport chain represent an important class of human
mitochondrial diseases that include Leigh Syndrome, Leber’s hereditary optic nephropathy, neonatal lactic
acidosis, cardiomyopathy, and encephalopathy. Leigh Syndrome is generally regarded as the most common
mitochondrial disease of infancy and is characterized primarily by severe neurological defects. There is
currently no effective treatment. A mouse model has been developed in which the complex I structural subunit
NDUFS4 is knocked-out. Ndufs4-/- mice show a profound neurodegenerative phenotype including retarded
growth rate, lethargy, loss of motor skill, blindness, weight loss, and early death. These symptoms are
recapitulated in human patients with Ndufs4 mutations, as well as other Leigh Syndrome-associated mutations.
We have recently reported that treating Ndufs4-/- mice with the drug rapamycin, a specific inhibitor of the
mammalian target of rapamycin complex 1 (mTORC1), results in two to three-fold increase in survival,
dramatic attenuation of neurologial defecits, and reduced neurodegeneration. In unpublished studies, we have
observed similar effects from the NAD+ precursor nicotinamide mononucleotide (NMN) -glucosidase
inhibitor acarbose. The broader goals this proposal to define the mechanistic basis for suppression of
mitochondrial disease by rapamycin, NMN, and acarbose in the Ndufs4 knockout (KO) mouse. This will be
accomplished broadly by assessing changes in the metabolome and phosphoproteome, and specifically by
determining the effects of these interventions on mitochondrial function, mTOR signaling, NAD homeostasis,
and activity of the NAD-dependent mitochondrial SIRT3 deacetylase. We will test the specific hypothesis that
these intervention act by enhancing SIRT3 activity by creating animals lacking both NDUFS4 and SIRT3 and
determining whether this blocks or attenuates rescue of the disease. These studies promise to enhance our
understanding of mitochondrial function in the context of complex I deficiency and facilitate the development of
interventional strategies to improve the lives of patients with mitochondrial disease.
7.项目总结/摘要
线粒体电子传递链复合体I中的缺陷代表了一类重要的人类
线粒体疾病,包括Leigh综合征,Leber遗传性视神经肾病,新生儿乳酸
酸中毒心肌病和脑病利氏综合征通常被认为是最常见的
线粒体疾病是婴儿期的疾病,其主要特征是严重的神经缺陷。有
目前没有有效的治疗方法。已经开发了一种小鼠模型,其中复合物I结构亚基
NDUFS 4被淘汰。NDUFs 4-/-小鼠表现出严重的神经退行性表型,包括发育迟缓
生长速度、嗜睡、运动技能丧失、失明、体重减轻和过早死亡。这些症状
在具有Ndufs 4突变以及其他Leigh综合征相关突变的人类患者中重现。
我们最近报告称,用药物雷帕霉素(一种特异性抑制剂)治疗Ndufs 4-/-小鼠
雷帕霉素复合物1的哺乳动物靶标(mTORC 1),导致存活率增加2至3倍,
神经学缺陷显着减弱,神经退行性变减少。在未发表的研究中,
观察到NAD+前体烟酰胺单核苷酸(NMN)-葡萄糖苷酶的类似作用
抑制剂阿卡波糖。更广泛的目标,这项建议,以确定机制的基础上,抑制
在Ndufs 4敲除(KO)小鼠中,雷帕霉素、NMN和阿卡波糖引起的线粒体疾病。这将是
通过评估代谢组和磷酸化蛋白质组的变化,特别是通过
确定这些干预对线粒体功能、mTOR信号传导、NAD稳态的影响,
和NAD依赖性线粒体SIRT 3脱乙酰酶的活性。我们将检验以下特定假设:
这些干预通过产生缺乏NDUFS 4和SIRT 3的动物来增强SIRT 3活性,
确定这是否阻断或减弱疾病的挽救。这些研究有望提高我们的
理解线粒体功能的背景下,复杂的I缺乏,并促进发展,
改善线粒体疾病患者生活的干预策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATT KAEBERLEIN其他文献
MATT KAEBERLEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATT KAEBERLEIN', 18)}}的其他基金
Developing the Privately Owned Companion Dog as a Model for Alzheimers Disease
开发私人伴侣犬作为阿尔茨海默病的模型
- 批准号:
10278879 - 财政年份:2021
- 资助金额:
$ 47.97万 - 项目类别:
Project 4: Determining the ability of rapamycin to improve lifespan and healthspan in companion dogs
项目4:确定雷帕霉素改善伴侣犬寿命和健康的能力
- 批准号:
10213631 - 财政年份:2018
- 资助金额:
$ 47.97万 - 项目类别:
Project 4: Determining the ability of rapamycin to improve lifespan and healthspan in companion dogs
项目4:确定雷帕霉素改善伴侣犬寿命和健康的能力
- 批准号:
10440341 - 财政年份:2018
- 资助金额:
$ 47.97万 - 项目类别:
Emergent properties of signaling network degradation that mediate homeostatic failure during aging
信号网络退化的新兴特性介导衰老过程中的稳态失败
- 批准号:
10207412 - 财政年份:2017
- 资助金额:
$ 47.97万 - 项目类别:
Emergent properties of signaling network degradation that mediate homeostatic failure during aging
信号网络退化的新兴特性介导衰老过程中的稳态失败
- 批准号:
9927555 - 财政年份:2017
- 资助金额:
$ 47.97万 - 项目类别:
Emergent properties of signaling network degradation that mediate homeostatic failure during aging
信号网络退化的新兴特性介导衰老过程中的稳态失败
- 批准号:
9368700 - 财政年份:2017
- 资助金额:
$ 47.97万 - 项目类别:
45th Annual Meeting of the American Aging Association
美国老龄化协会第 45 届年会
- 批准号:
9125677 - 财政年份:2016
- 资助金额:
$ 47.97万 - 项目类别:
Defining the Mechanisms of genotype-dependent responses to caloric restriction
定义基因型依赖性热量限制反应机制
- 批准号:
8523731 - 财政年份:2011
- 资助金额:
$ 47.97万 - 项目类别:
Lifespan and healthspan regulation by hypoxic response transcription factor HIF-1
缺氧反应转录因子 HIF-1 对寿命和健康的调节
- 批准号:
8441592 - 财政年份:2011
- 资助金额:
$ 47.97万 - 项目类别:
Lifespan and healthspan regulation by hypoxic response transcription factor HIF-1
缺氧反应转录因子 HIF-1 对寿命和健康的调节
- 批准号:
8664325 - 财政年份:2011
- 资助金额:
$ 47.97万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 47.97万 - 项目类别:
Research Grant